Ensoma Announces Closing of Twelve Bio Acquisition

Your unfiltered news center. ®

The world you see depends upon the news you get. ®

HOME

ARTS

RSS

Today's Date: April 26, 2024

In Support of PEPSI® x Mary J. Blige Strength of a Woman Partnership, The Brand Launches $100,000 Fund to Support Yonkers Wo • LENNAR NOW SELLING THREE NEW-HOME COLLECTIONS AT JUNIPERS, SAN DIEGO'S RESORT-STYLE COMMUNITY FOR ACTIVE ADULTS AGED 55 AND BETT • Kinaxis Positioned Highest on Ability to Execute in the Gartner® Magic Quadrant™ for Supply Chain Planning Solutions • Manulife Investment Management Announces Forest Climate Fund's Second Close Bringing Total Commitments Up to $334.5 Million • Chase Opens Innovative Branch in Bronx’s Grand Concourse Neighborhood • Operation HOPE and SBA Forge Strategic Alliance to Empower Small Businesses Across America • Emmy-winning Cyberchase Expands Digital Presence to Engage Every Kid, Everywhere Ahead of Season 15 Premiere • McCain Foods Plants 18,000 Trees in Wisconsin, Fulfilling 2022 Promise to Plover Community • Coastal Carolina, Southwestern Law School, and Other Institutions Streamline Accessibility Workflows With YuJa's PDF Remediation • C2N Diagnostics Expands Into Japan Through Mediford Corporation Partnership With Precivity™ Blood Testing for Alzheimer&rs • 29 London Partners With US Media Company Bobi Media to Strengthen Market Offering • Suzano 2023 annual report on Form 20-F • Dual Enrollment Helps High School Students Launch Rewarding Careers • United Imaging Healthcare Releases 2023 ESG Report, Advancing Mission of Equal Healthcare for All™ • United Imaging Healthcare releases 2023 annual report, with revenue growth of 23.52% • BeiGene Demonstrates Global Progress in 2023 Responsible Business & Sustainability Report • Carbon Removal and Mariculture Legislation Moves Forward in California Assembly • Disneyland Resort Celebrates Return of Pixar Fest for a Limited Time, April 26-Aug. 4, 2024 • The Sallie Mae Fund Grants $75,000 to DC College Access Program to Support Higher Education Access and Completion • Nonprofits from Inception Fertility and Caden Lane Team Up to Expand Financial Accessibility to Fertility Care

Ensoma Announces Closing of Twelve Bio Acquisition

BOSTON , February 09 /Businesswire/ - Ensoma, a genomic medicines company developing one-time in vivo treatments that precisely engineer any cell of the hematopoietic system to cure diseases from within, today announced the closing of its previously announced acquisition of Twelve Bio ApS, a gene editing company pioneering the therapeutic application of next-generation CRISPR-Cas medicines. The closing follows recent clearance by the Danish Business Authority pursuant to Danish foreign direct investment laws.

In conjunction with the closing, Stefano Stella, Ph.D., co-founder of Twelve Bio, has joined the leadership team at Ensoma as vice president of gene editing. Additionally, Guillermo Montoya, Ph.D., co-founder of Twelve Bio, and Shengdar Q. Tsai, Ph.D., a leading expert in genome engineering and hematology and member of the scientific advisory board of Twelve Bio, will join the scientific advisory board at Ensoma.

About Ensoma

Ensoma believes the future of medicine lies within us. The company’s Engenious™ platform combines innovative delivery technology with the full DNA editing toolkit to tackle diseases that affect millions around the world, such as cancer and autoimmune disease, as well as inherited conditions. Ensoma is supported by top-tier investors, a strategic collaboration with Takeda and a passionate team committed to a bold, global vision for genomic medicine. Ensoma is headquartered in Boston, with additional research operations in Copenhagen, Denmark. For more information, visit ensoma.com.